Last checked at 14 Jun 2023 12:28
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU) NO.596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"), AS AMENDED.
14 June 2023
Belluscura plc
("Belluscura", the "Company" or the "Group")
Result of General Meeting
Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that at the General Meeting held today at 11.00 a.m. all the resolutions proposed were duly passed by the requisite majority:
Resolution (*indicates special resolution) | Votes for | % of shares voted | Votes against | % of shares voted | Total votes |
Resolution 1: Authority to allot shares in connection with the Placing, the Subscriptions and Retail Offer | 43,674,769 | 99.92% | 36,466 | 0.08% | 43,711,235 |
Resolution 2*: Disapplication of pre-emption rights in connection with the Placing, Subscriptions and Retail Offer | 43,673,774 | 99.91% | 37,461 | 0.09% | 43,711,235 |
For further information please contact:
Belluscura plc | Tel: +44 (0)20 3128 8100 |
Adam Reynolds, Chairman Robert Rauker, Chief Executive Officer Anthony Dyer, Chief Financial Officer | |
SPARK Advisory Partners Limited (Nomad) | Tel: +44 (0)20 3368 3550 |
Neil Baldwin | |
Dowgate Capital Limited (Broker) | Tel: +44 (0)20 3903 7715 |
James Serjeant / Russell Cook | |
MHP (Financial PR & Investor Relations) | Tel: +44 (0)20 3128 8100 |
Katie Hunt / Matthew Taylor | belluscura@mhpgroup.com |